These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21840928)

  • 21. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy.
    Liu H; Yazdani A; Murray LM; Beauvais A; Kothary R
    PLoS One; 2014; 9(7):e101225. PubMed ID: 24984019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal Muscle Atrophy.
    Lomonte P; Baklouti F; Binda O
    Biochemistry; 2020 Apr; 59(14):1391-1397. PubMed ID: 32227847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.
    Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L
    Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of exercise-induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy-like mice.
    Ng SY; Mikhail A; Ljubicic V
    J Physiol; 2019 Sep; 597(18):4757-4778. PubMed ID: 31361024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.
    Tsai LK; Tsai MS; Ting CH; Li H
    J Mol Med (Berl); 2008 Nov; 86(11):1243-54. PubMed ID: 18649067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
    J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA).
    Fayzullina S; Martin LJ
    PLoS One; 2014; 9(3):e93329. PubMed ID: 24667816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal Muscular Atrophy autophagy profile is tissue-dependent: differential regulation between muscle and motoneurons.
    Sansa A; Hidalgo I; Miralles MP; de la Fuente S; Perez-Garcia MJ; Munell F; Soler RM; Garcera A
    Acta Neuropathol Commun; 2021 Jul; 9(1):122. PubMed ID: 34217376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy.
    Deguise MO; Boyer JG; McFall ER; Yazdani A; De Repentigny Y; Kothary R
    Sci Rep; 2016 Jun; 6():28846. PubMed ID: 27349908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK; Chen CL; Tsai YC; Ting CH; Chien YH; Lee NC; Hwu WL
    Hum Mol Genet; 2016 Feb; 25(4):631-41. PubMed ID: 26647309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy.
    Taylor AS; Glascock JJ; Rose FF; Lutz C; Lorson CL
    Transgenic Res; 2013 Oct; 22(5):1029-36. PubMed ID: 23512182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing SMN levels using the histone deacetylase inhibitor SAHA ameliorates defects in skeletal muscle microvasculature in a mouse model of severe spinal muscular atrophy.
    Somers E; Riessland M; Schreml J; Wirth B; Gillingwater TH; Parson SH
    Neurosci Lett; 2013 Jun; 544():100-4. PubMed ID: 23583590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy.
    Boyd PJ; Tu WY; Shorrock HK; Groen EJN; Carter RN; Powis RA; Thomson SR; Thomson D; Graham LC; Motyl AAL; Wishart TM; Highley JR; Morton NM; Becker T; Becker CG; Heath PR; Gillingwater TH
    PLoS Genet; 2017 Apr; 13(4):e1006744. PubMed ID: 28426667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
    Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
    Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy.
    Wishart TM; Mutsaers CA; Riessland M; Reimer MM; Hunter G; Hannam ML; Eaton SL; Fuller HR; Roche SL; Somers E; Morse R; Young PJ; Lamont DJ; Hammerschmidt M; Joshi A; Hohenstein P; Morris GE; Parson SH; Skehel PA; Becker T; Robinson IM; Becker CG; Wirth B; Gillingwater TH
    J Clin Invest; 2014 Apr; 124(4):1821-34. PubMed ID: 24590288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
    Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.
    Rindt H; Buckley DM; Vale SM; Krogman M; Rose FF; Garcia ML; Lorson CL
    Neuromuscul Disord; 2012 Mar; 22(3):277-85. PubMed ID: 22079083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.